Form 4: Pulmonx Officer Sells Shares for Tax Withholding

Pulmonx Corp reports a Form 4 filing detailing the sale of common stock by Chief Commercial Officer Geoffrey Beran to cover tax withholding obligations.

Summary

• Geoffrey Beran, Chief Commercial Officer of Pulmonx Corporation, sold a total of 7,023 shares of common stock on June 1, 2026.
• These sales were conducted to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• The sales occurred in four tranches, with prices ranging from $1.54 per share.
• Following these transactions, Mr. Beran beneficially owns 457,711 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as the stock sales are for tax withholding purposes related to RSU vesting, a common and expected event for insiders.

Negatives

• Sale of company stock by a key executive, which could be perceived negatively by the market, although it is for tax withholding purposes.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily details past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. The sale of shares by a Chief Commercial Officer to cover tax obligations upon RSU vesting is a common occurrence and typically does not signal a negative view of the company's prospects by the executive, but rather a standard financial planning event.

Stakeholder Impact

• Shareholders: The sale of shares by an executive may lead to short-term market perception concerns, though the reason for the sale (tax withholding) mitigates this impact.

Key Dates

Keywords

Pulmonx Corp, LUNG, Form 4, Stock Sale, Tax Withholding, RSU Vesting, Beneficial Ownership, Geoffrey Beran